Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 19, 2021
Total-Body PET Multiparametric Imaging of Cancer Using a Voxelwise Strategy of Compartmental Modeling
Guobao Wang, Lorenzo Nardo, Mamta Parikh, et al.
Scientific Reports
|
March 19, 2021
Phase Ib trial of reformulated niclosamide with abiraterone/prednisone in men with castration-resistant prostate cancer
Mamta Parikh, Chengfei Liu, Chun-Yi Wu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 28, 2024
High-Temporal-Resolution Kinetic Modeling of Lung Tumors with Dual-Blood Input Function Using Total-Body Dynamic PET
Yiran Wang, Yasser G Abdelhafez, Benjamin A Spencer, et al.
Cancer
|
June 19, 2026
Patient-reported outcomes in castration-resistant prostate cancer with bone metastases treated with radium-223 with or without olaparib
Rana R McKay, Wanling Xie, Archana Ajmera, et al.
Biomedicines
|
May 27, 2026
Characterizing Response to PARP Inhibitor Treatment Combinations in Advanced Prostate Cancer
Bryan Correa Gonzalez, Akshaya Karthikeyan, Love A Moore, et al.
Prostate Cancer and Prostatic Diseases
|
February 29, 2024
Markers of bone metabolism and overall survival in men with bone-metastatic hormone sensitive prostate cancer (HSPC): A subset analysis of SWOG S1216, a phase III trial of androgen deprivation with or without orteronel
Primo N Lara, Edward Mayerson, Erik Gertz, et al.
Nanomedicine (London, England)
|
June 2, 2026
A Phase I trial of PLZ4-coated paclitaxel-loaded micelles in patients with refractory non-muscle-invasive bladder cancer
Athira Narayan, Ryan C Leibrandt, Joyce S Lee, et al.
Endocrine-Related Cancer
|
May 1, 2025
Real-world effectiveness of darolutamide in metastatic castration-resistant prostate cancer
Alyssa Liang, Shuchi Gulati, Quillan Huang, et al.
Scientific Reports
|
June 14, 2023
Cisplatin-induced increase in heregulin 1 and its attenuation by the monoclonal ErbB3 antibody seribantumab in bladder cancer
Thomas M Steele, Maria Malvina Tsamouri, Salma Siddiqui, et al.
Molecular Cancer Therapeutics
|
December 5, 2025
IGFBP3-SphK1/S1P Signaling Axis Drives Enzalutamide Resistance in Advanced Prostate Cancer
Amy R Leslie, Shu Ning, Masuda Sharifi, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 19, 2021
Total-Body PET Multiparametric Imaging of Cancer Using a Voxelwise Strategy of Compartmental Modeling
Guobao Wang, Lorenzo Nardo, Mamta Parikh, et al.
Scientific Reports
|
March 19, 2021
Phase Ib trial of reformulated niclosamide with abiraterone/prednisone in men with castration-resistant prostate cancer
Mamta Parikh, Chengfei Liu, Chun-Yi Wu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 28, 2024
High-Temporal-Resolution Kinetic Modeling of Lung Tumors with Dual-Blood Input Function Using Total-Body Dynamic PET
Yiran Wang, Yasser G Abdelhafez, Benjamin A Spencer, et al.
Cancer
|
June 19, 2026
Patient-reported outcomes in castration-resistant prostate cancer with bone metastases treated with radium-223 with or without olaparib
Rana R McKay, Wanling Xie, Archana Ajmera, et al.
Biomedicines
|
May 27, 2026
Characterizing Response to PARP Inhibitor Treatment Combinations in Advanced Prostate Cancer
Bryan Correa Gonzalez, Akshaya Karthikeyan, Love A Moore, et al.
Prostate Cancer and Prostatic Diseases
|
February 29, 2024
Markers of bone metabolism and overall survival in men with bone-metastatic hormone sensitive prostate cancer (HSPC): A subset analysis of SWOG S1216, a phase III trial of androgen deprivation with or without orteronel
Primo N Lara, Edward Mayerson, Erik Gertz, et al.
Nanomedicine (London, England)
|
June 2, 2026
A Phase I trial of PLZ4-coated paclitaxel-loaded micelles in patients with refractory non-muscle-invasive bladder cancer
Athira Narayan, Ryan C Leibrandt, Joyce S Lee, et al.
Endocrine-Related Cancer
|
May 1, 2025
Real-world effectiveness of darolutamide in metastatic castration-resistant prostate cancer
Alyssa Liang, Shuchi Gulati, Quillan Huang, et al.
Scientific Reports
|
June 14, 2023
Cisplatin-induced increase in heregulin 1 and its attenuation by the monoclonal ErbB3 antibody seribantumab in bladder cancer
Thomas M Steele, Maria Malvina Tsamouri, Salma Siddiqui, et al.
Molecular Cancer Therapeutics
|
December 5, 2025
IGFBP3-SphK1/S1P Signaling Axis Drives Enzalutamide Resistance in Advanced Prostate Cancer
Amy R Leslie, Shu Ning, Masuda Sharifi, et al.
Page
of 5